Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
The rhesus monkey intrinsic immunity factor TRIM5alpha(rh) recognizes incoming capsids from a variety of retroviruses, including human immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV), and inhibits the accumulation of viral reverse transcripts. However, direct interactions between restricting TRIM5alpha proteins and retroviral capsids have not previously been demonstrated using pure recombinant proteins. To facilitate structural and mechanistic studies of retroviral restriction, we have developed methods for expressing and purifying an active chimeric TRIM5alpha(rh) protein containing the RING domain from the related human TRIM21 protein. This recombinant TRIM5-21R protein was expressed in SF-21 insect cells and purified through three chromatographic steps. Two distinct TRIM5-21R species were purified and shown to correspond to monomers and dimers, as analyzed by analytical ultracentrifugation. Chemically cross-linked recombinant TRIM5-21R dimers and mammalian-expressed TRIM5-21R and TRIM5alpha proteins exhibited similar sodium dodecyl sulfate-polyacrylamide gel electrophoresis mobilities, indicating that mammalian TRIM5alpha proteins are predominantly dimeric. Purified TRIM5-21R had ubiquitin ligase activity and could autoubquitylate with different E2 ubiquitin conjugating enzymes in vitro. TRIM5-21R bound directly to synthetic capsids composed of recombinant HIV-1 CA-NC proteins and to authentic EIAV core particles. HIV-1 CA-NC assemblies bound dimeric TRIM5-21R better than either monomeric TRIM5-21R or TRIM5-21R constructs that lacked the SPRY domain or its V1 loop. Thus, our studies indicate that TRIM5alpha proteins are dimeric ubiquitin E3 ligases that recognize retroviral capsids through direct interactions mediated by the SPRY domain and demonstrate that these activities can be recapitulated in vitro using pure recombinant proteins.
Langelier
Charles R
CR
Department of Biochemistry, University of Utah, Salt Lake City, UT 84112-5650, USA.
Sandrin
Virginie
V
Eckert
Debra M
DM
Christensen
Devin E
DE
Chandrasekaran
Viswanathan
V
Alam
Steven L
SL
Aiken
Christopher
C
Olsen
John C
JC
Kar
Alak Kanti
AK
Sodroski
Joseph G
JG
Sundquist
Wesley I
WI
D002213:Capsid / Q000737:chemistry / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000502:physiology; D019281:Dimerization; D015497:HIV-1 / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D009687:Nuclear Proteins / Q000737:chemistry* / Q000502:physiology; D019251:Nucleocapsid / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000737:chemistry* / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000737:chemistry* / Q000302:isolation & purification; D012261:Ribonucleoproteins; D025801:Ubiquitin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism; D014779:Virus Replication; D000099207:SS-A Antigen
D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D011506:Proteins; D011993:Recombinant Fusion Proteins; D012261:Ribonucleoproteins; D025801:Ubiquitin; D044767:Ubiquitin-Protein Ligases; D000099207:SS-A Antigen; C482587:TRIM5(alpha) protein, rhesus monkey
J Mol Biol. 2008 Mar 21;377(2):431-49
18272178
J Virol. 2002 Jun;76(11):5667-77
11991995
Mol Cell. 2006 Mar 17;21(6):873-80
16543155
J Biol Chem. 1990 Sep 15;265(26):15813-7
2203788
Retrovirology. 2004 May 14;1:9
15169567
EMBO J. 1986 Dec 1;5(12):3133-42
3102226
Nat Immunol. 2004 Nov;5(11):1109-15
15496950
Cell. 1996 Dec 27;87(7):1285-94
8980234
Virology. 2006 Aug 1;351(2):404-19
16650449
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7465-70
16648264
Virology. 2007 Apr 10;360(2):419-33
17156811
EMBO J. 2003 Apr 1;22(7):1707-15
12660176
Nat Struct Mol Biol. 2007 Oct;14(10):941-8
17873885
J Virol. 2005 Nov;79(22):14446-50
16254380
Virology. 2006 Sep 30;353(2):396-409
16828831
J Virol. 2000 Feb;74(3):1168-77
10627527
J Virol. 2000 Jul;74(13):6198-202
10846106
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9564-8
7937806
Gene Ther. 2005 Jan;12(1):22-9
15550928
J Virol. 2005 Aug;79(16):10571-7
16051849
Nature. 2000 Sep 21;407(6802):409-13
11014200
J Virol. 2006 Sep;80(17):8554-65
16912305
Methods Enzymol. 2005;399:21-36
16338346
J Virol. 2006 Oct;80(19):9754-60
16973579
Virology. 2007 Dec 20;369(2):400-10
17920096
Mol Cell. 2005 Nov 23;20(4):525-38
16307917
Gene. 2005 Dec 5;362:109-16
16226405
Virology. 2006 Jun 5;349(2):300-15
16472833
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5514-9
16540544
Exp Cell Res. 2003 Aug 1;288(1):84-93
12878161
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6200-5
17400754
J Mol Biol. 1999 Feb 12;286(1):83-93
9931251
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10780-5
15249687
J Virol. 2005 Jan;79(2):869-75
15613315
J Biol Chem. 2005 Mar 18;280(11):10548-55
15644320
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2832-7
15689398
FEBS J. 2008 Apr;275(7):1540-1555
18312418
J Virol. 1995 Oct;69(10):6487-97
7666550
Virology. 2007 Sep 1;365(2):302-14
17493656
J Virol. 2007 Oct;81(19):10362-78
17626085
Science. 1999 Jan 1;283(5398):80-3
9872746
PLoS Pathog. 2008 May 23;4(5):e1000074
18497858
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91
15249690
J Virol. 2007 Mar;81(5):2138-48
17135314
Curr Opin Struct Biol. 2008 Apr;18(2):203-17
18406133
J Virol. 1998 Mar;72(3):1902-9
9499042
Mol Immunol. 2006 Feb;43(6):588-98
15916807
Virology. 2006 Jul 5;350(2):493-500
16624363
J Cell Biol. 2008 Feb 11;180(3):549-61
18250195
Cell. 2007 Oct 5;131(1):70-9
17923088
J Virol. 2006 Jul;80(14):6738-44
16809279
Methods Enzymol. 2004;384:212-32
15081689
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32
15280539
Retrovirology. 2007 Jun 12;4:40
17565686
Virology. 2006 Sep 15;353(1):234-46
16808955
J Mol Biol. 1997 Jun 27;269(5):780-95
9223641
Mol Immunol. 2007 Mar;44(9):2406-14
17118455
J Virol. 1999 Oct;73(10):8824-30
10482638
J Virol. 2005 Mar;79(5):3139-45
15709033
Curr Biol. 2005 Jan 11;15(1):73-8
15649369
J Biol Chem. 2005 Jul 22;280(29):26933-40
15897199
J Virol. 2006 Apr;80(8):4061-7
16571822
PLoS Pathog. 2007 Dec;3(12):e197
18159944
J Virol. 2005 Jul;79(14):8969-78
15994791
Nature. 2004 Feb 26;427(6977):848-53
14985764
Biochim Biophys Acta. 2001 Dec 5;1568(2):155-61
11750763
Biochem Biophys Res Commun. 1989 Apr 28;160(2):486-94
2541703
Virology. 2005 Dec 20;343(2):201-11
16183097
J Virol. 2005 May;79(10):6111-21
15857996
Retrovirology. 2005 Jun 20;2:40
15967037
Mol Cell. 2006 Dec 28;24(6):967-76
17189197
J Biol Chem. 2006 Jan 6;281(1):528-42
16195228
EMBO J. 2003 Feb 3;22(3):385-94
12554640